Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460
- PMID: 35142702
- PMCID: PMC9946064
- DOI: 10.1097/MJT.0000000000001482
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460
Conflict of interest statement
The author has no conflicts of interest to declare.
Comment in
-
Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232.Am J Ther. 2022 Jul 1;29(4):455-459. doi: 10.1097/MJT.0000000000001520. Am J Ther. 2022. PMID: 35802915 Free PMC article. No abstract available.
Expression of concern for
-
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.Am J Ther. 2021 Jun 21;28(4):e434-e460. doi: 10.1097/MJT.0000000000001402. Am J Ther. 2021. PMID: 34145166 Free PMC article.
References
-
- Lawrence JM, Meyerowitz-Katz G, Heathers JA, et al. . The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable. Nat Med. 2021;27:1853–1854. - PubMed
-
- Rothrock SG, Weber KD, Giordano PA, et al. . Meta-Analyses do not establish improved mortality with ivermectin use in COVID-19. Am J Ther. 2022;29:e87–e94. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials